Our team has demonstrated that oxidative stress, triggered by high glucose, increases T14 peptide levels in vitro and reduces cell viability. The cyclic form of T14, NBP14, blocked these toxic effects, suggesting its potential as a therapeutic agent. These findings highlight that oxidative stress could activate T14 in the adult brain through AChE upregulation, contributing to neurodegeneration in Alzheimer’s disease.
LATEST NEWS
- Our Office Manager Charles Monro attended the new opening of the reception area at UK Atomic Energy Authority
- Neuro-Bio welcomes back Adam Khan
- Charles Munro, our Office Manager attends Culham Campus Quarterly Tenant lunch
- Neuro-Bio welcomes Amy Lewis
- New lateral flow test may detect Alzheimer’s decades early! In collaboration with Aptamer Group!